AI risks, consumer weakness, bond market warnings, and tariffs are shaping the outlook for investors and the broader economy.

Michigan’s Senate primary highlights the growing divide within the Democratic Party, with the outcome potentially shaping the balance of power in Congress.

Trump is requiring generic drugmakers to move production to the U.S. or pay a 100% import tariff beginning in August 2028, a policy that could reshape the supply of low-cost medicines for millions of Americans.

The House advanced a $95 billion budget framework that includes defense and farm funding, with analysts watching how future spending decisions could shape U.S. policy priorities.

Investors are increasingly looking to Washington—not just Wall Street—for market signals, as government policy plays a growing role in shaping industry winners and losers.

Henrietta Treyz of Veda Partners says Congress is running out of time to deliver additional pre-election stimulus, while AI regulation is poised to become a major focus after November.

President Trump has joined calls for giving U.S. taxpayers ownership stakes in AI companies, though analysts remain skeptical.

Congress faces a packed legislative schedule and limited time to act before the summer recess, putting pressure on lawmakers to address several high-profile issues.

As tensions in the Middle East persist, policymakers face growing political pressure at home with the midterm elections drawing closer.